Teligent Gets Immediate Access to $6M in Fresh Cash for Bankruptcy -- Market Talk
Teligent Gets Immediate Access to $6M in Fresh Cash for Bankruptcy -- Market Talk
1426 ET - Teligent received court approval to immediately receive $6M in fresh financing from its lenders to help it get through bankruptcy. The publicly traded drug maker sought protection from creditors Wednesday after the Food and Drug Administration flagged problems at the company's plant in Buena, N.J., leading to a recall and production halt. The pandemic also reduced demand for Teligent's skin products as elective visits to doctors' offices slowed. It is scheduled to return to the U.S. Bankruptcy Court in Wilmington, Del., next month for final approval of financing that includes another $6M in new money. (becky.yerak@wsj.com; @beckyyerak)
1426 ET-Teligent 獲得法院批准，立即從其貸款人那裡獲得 6 萬美元的新鮮融資，以幫助其度過破產。在食品和藥物管理局（FDA）在公司位於新澤西州布納的工廠標記問題之後，這家公開交易的製藥商週三向債權人尋求保護，導致召回和生產停止。隨著對醫生辦公室的選修訪問放緩，大流行還減少了對 Teligent 皮膚產品的需求。它計劃在下個月返回美國位於德拉瓦州威爾明頓的破產法院進行最終批准，其中包括另外 6 萬美元的新資金。(becky.yerak@wsj.com; @beckyyerak)
譯文內容由第三人軟體翻譯。